A judge denied compounders' request to keep making off-brand Wegovy and Ozempic after the FDA removed semaglutide from its shortage list.

Many Americans are taking GLP1 medications, which include weight loss and diabetes medications Ozempic and Wegovy.

A Howard County man is suing Novo Nordisk, alleging Ozempic caused him to go blind after using the drug to treat diabetes. He seeks damages in court.

The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and ...

It is better for doctors and for the healthcare system when more people are sick and rely on medical interventions.

Meanwhile, others with the condition have seen vast improvements in their health with “CFTR modulator” therapies that work ...

Treating and managing type 2 diabetes successfully can require a team. Learn from these specialists how to hit your health ...

Two years on from The Royal Gazette’s first report on a new wave of diabetes drugs with broader health benefits, the island’s ...

Researchers at Thomas Jefferson University have found a new way to help. Their study showed that using two diabetes ...

A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...

In patients with T2D who had been hospitalized for poorly controlled blood glucose, SGLT2 inhibitors nearly doubled the risk for falls, and combined use with GLP-1 RAs nearly tripled the risk.